Compound Detail
CHEMBL226630
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL226630 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ARJCBSRIPGJMAD-LLVKDONJSA-N |
6
Targets
8
Activities
1
Assay Types
13
PK Parameters
20
Publications
0
Known Names
Molecular Properties
324.4
MW (Da)
1.90
ALogP
6
HBA
3
HBD
131.3
PSA (Ų)
0.49
QED
0
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 8 meas. best 7.58
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Bone morphogenetic protein 1 CHEMBL3898 | IC50 | 7.58 | 7.4333 | 26.0 | 3 |
| 3',5'-cyclic-AMP phosphodiesterase 4D CHEMBL288 | IC50 | 6.05 | 6.05 | 900.0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase 4B CHEMBL275 | IC50 | 5.82 | 5.82 | 1500.0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase 4A CHEMBL254 | IC50 | 5.75 | 5.75 | 1800.0 | 1 |
| Fibroblast CHEMBL613838 | IC50 | 5.68 | 5.68 | 2100.0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase 4C CHEMBL291 | IC50 | 5.62 | 5.62 | 2400.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 157.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 35.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| Cmax | 339.11 | nM | Canis lupus familiaris |
| F | 13.0 | % | Canis lupus familiaris |
| T1/2 | 0.8 | hr | Rattus norvegicus |
| T1/2 | 1.5 | hr | Canis lupus familiaris |
| T1/2 | 0.3167 | hr | Homo sapiens |
| T1/2 | 0.15 | hr | Canis lupus familiaris |
| T1/2 | 0.03333 | hr | Rattus norvegicus |
| T1/2 | 0.8 | hr | Rattus norvegicus |
| Tmax | 0.5 | hr | Canis lupus familiaris |
| Vd | 12.0 | L.kg-1 | Rattus norvegicus |
| Vd | 4.6 | L.kg-1 | Canis lupus familiaris |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Bone morphogenetic protein 1 | IC50 | = | 26.0 | nM | 7.58 | Inhibition of human procollagen C-proteinase assessed as [3H]procollagen turnove... | 18945617 |
| Bone morphogenetic protein 1 | IC50 | = | 44.0 | nM | 7.36 | Inhibition of human procollagen C-proteinase expressed in CHO cells | 17591762 |
| Bone morphogenetic protein 1 | IC50 | = | 44.0 | nM | 7.36 | Inhibition of human procollagen C-proteinase expressed in CHO cells by fluoresce... | 18945617 |
| 3',5'-cyclic-AMP phosphodiesterase 4D | IC50 | = | 900.0 | nM | 6.05 | Inhibition of PDE4D | 18945617 |
| 3',5'-cyclic-AMP phosphodiesterase 4B | IC50 | = | 1500.0 | nM | 5.82 | Inhibition of PDE4B | 18945617 |
| 3',5'-cyclic-AMP phosphodiesterase 4A | IC50 | = | 1800.0 | nM | 5.75 | Inhibition of PDE4A | 18945617 |
| Fibroblast | IC50 | = | 2100.0 | nM | 5.68 | Reduction in collagen deposition in human fibroblasts after 8 days by HPLC | 18945617 |
| 3',5'-cyclic-AMP phosphodiesterase 4C | IC50 | = | 2400.0 | nM | 5.62 | Inhibition of PDE4C | 18945617 |
Literature References
Data from ChEMBL 36 via Core Engine